Stimuli-responsive prodrug-based cancer nanomedicine

Stimuli-responsive prodrug-based cancer nanomedicine

The rapid development of nanotechnology results in the emergence of nanomedicines, but the effective delivery of drugs to tumor sites remains a great challenge. Prodrug-based cancer nanomedicines thus emerged due to their unique advantages, including high drug load efficiency, reduced side effects,...

Full description

Bibliographic Details
Main Authors: Angel Xie, Sumaira Hanif, Jiang Ouyang, Zhongmin Tang, Na Kong, Na Yoon Kim, Baowen Qi, Dylan Patel, Bingyang Shi, Wei Tao
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:EBioMedicine
Subjects:
Cancer therapy
Nanomedicine
Prodrug
Stimuli-responsive
Polymer
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396420301961

Internet

http://www.sciencedirect.com/science/article/pii/S2352396420301961

Similar Items